Xoma | XOMA - صافي الدخل





صافي الدخل تغيير تاريخ
AbbVie USD 1.82B 1.63B 2025-12
Agenus USD -10.63M 74.49M 2025-12
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Ardelyx USD -407K 562K 2025-12
aTyr Pharma USD 24.56M 50.3M 2025-12
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Celldex Therapeutics USD -81.32M 14.27M 2025-12
Curis USD -11.8M 80K 2024-06
Eli Lilly USD 6.64B 1.05B 2025-12
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Incyte USD 299.28M 124.89M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Novartis USD 2.41B 1.52B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Prothena USD -21.59M 14.95M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Xoma USD -17.24M 33.23M 2024-09